NIH shifts noncritical research to maintenance March 20, 2020 -- The National Institutes of Health (NIH) has decided to shift all laboratory operations that are not mission critical to a maintenance phase, according to a statement released on March 20.
Illumina, IDbyDNA partner for COVID-19 surveillance March 17, 2020 -- IDbyDNA and Illumina have partnered to bring next-generation sequencing (NGS) workflows to the global microbiology market to combat the COVID-19 pandemic. The companies will accelerate and improve testing for infectious diseases with NGS surveillance technology.
AI visualization maps how SARS-CoV-2 spreads March 12, 2020 -- Artificial intelligence (AI) developer Graphen has published a visual analysis that demonstrates the evolution of SARS-CoV-2 across the world during the COVID-19 outbreak.
Dante Labs offers free whole-genome sequencing services to scientists March 11, 2020 -- Dante Labs, an Italy-based commercial genomics laboratory, announced it has started a program to support global scientific research on the novel coronavirus. As part of this program, the company will be offering 200 free human whole-genome sequencing tests to scientists working on coronavirus-related research.
National Postdoctoral Association cancels meeting due to COVID-19 March 11, 2020 -- Yet another scientific meeting has been canceled as a result of the rapidly spreading coronavirus disease (COVID-19) outbreak. On March 10, the National Postdoctoral Association made the decision to cancel its annual conference scheduled to take place in San Diego on March 27-29.
MilliporeSigma launches Lanexo software at Pittcon 2020 March 4, 2020 -- MilliporeSigma launched its Lanexo software for lab inventory, safety, and compliance management at the Pittcon meeting in Chicago on March 3. The new digital laboratory informatics software is designed to reduce time in labs and improve data quality and traceability.
Thermo Fisher set to acquire Qiagen after all in $11.5B deal March 3, 2020 -- After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will give Thermo Fisher access to Qiagen's molecular diagnostics expertise and potentially lead to faster development of diagnostic tests.